SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The community conversation is dominated by reactions to a campaign promise to issue a 5,000 dividend to every U.S. adult if Republicans win the upcoming midterms, with many traders labeling it a fiscally irresponsible "bribe" that would balloon the national debt. While supporters express enthusiasm for the proposal, significant skepticism persists regarding its feasibility and potential to worsen inflation.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense selling pressure as investors react to the company's upcoming removal from the S&P 100 and ongoing concerns over its weak earnings outlook, sluggish China sales, and a difficult turnaround. While the community is deeply divided, with many traders betting on further downside and criticizing management's leadership, some contrarian investors see the stock as a long-term value opportunity that is currently oversold.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The community is debating the potential economic impact of a proposed federal dividend payment, with discussions frequently centering on concerns over rising national debt, inflationary pressures, and the influence of upcoming inflation data on Federal Reserve policy. Traders remain cautious as higher energy costs and Treasury yields continue to weigh on market sentiment.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the unveiling of its first foldable smartphone, the iPhone Duo, alongside the iPhone 18 Pro lineup. Community discussion is polarized: while many retail traders are critical of the high price point and skeptical of foldable technology, others view the product as a significant innovation that could drive a new hardware supercycle.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as traders closely monitor rising Treasury yields and surging crude oil prices ahead of upcoming inflation reports. While sentiment remains divided, there is significant debate regarding the market's resilience against these macroeconomic pressures and the potential for a correction.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following an upbeat analyst conference where the company projected a massive expansion in the AI chip total addressable market by 2030, alongside strong forecasts for its data center and server CPU businesses. While many traders have responded with bullish sentiment and momentum-chasing, a segment of the community remains skeptical, debating whether the stock's valuation is driven by sustainable growth or an unsustainable speculative bubble.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to persistent volatility in oil prices driven by escalating military tensions in the Middle East and ongoing concerns regarding energy supply disruptions. Traders are actively debating whether this upward momentum is sustainable or if current geopolitical catalysts are being exaggerated by speculators in anticipation of potential mid-term policy shifts.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares are trending following a fiscal first-quarter earnings beat and a record funded backlog, despite the company maintaining its full-year guidance. While some traders are enthusiastic about the company's laser weapon systems and ongoing defense contracts, others express frustration over stagnant price action and suggest the stock is being suppressed by market makers.

American Eagle Outfitters, Inc. operates retail stores and e-commerce channels offering apparel, accessories, and personal care products under the American Eagle and Aerie brands. It also operates the OFFL/NE by Aerie, Todd Snyder, and Unsubscribed brands. The firm operates stores in the United States, Canada, and Mexico and sells its products through international license partners. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is experiencing significant volatility as investors weigh the potential for a short squeeze against concerns regarding the sustainability of growth following an earnings beat driven by one-time tariff refunds. Traders are closely monitoring the stock's performance ahead of holiday shopping results, with significant disagreement between bullish sentiment surrounding brand momentum and bearish skepticism about core brand weakness.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following an investor webinar that outlined the registrational path and clinical development plan for its lead pipeline asset, XP-8121, a once-weekly injectable levothyroxine. While the community is debating the 2030 launch timeline and the potential for a blockbuster sales opportunity, others are highlighting the company's strong revenue growth from its commercial portfolio as a sign of long-term value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards Program

Alkermes plc (Nasdaq: ALKS) today announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards program on Friday, Sept. 11, 2026. Now in its ninth year, this competitive grant program is designed to support the next generation of researchers working on the...

Alkermes Chief Commercial Officer Sells 7,576 Shares for $373,000

Alkermes Chief Commercial Officer Sells 7,576 Shares for $373,000...

Why Is Alkermes (ALKS) Up 1.7% Since Last Earnings Report?

Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Lancet Neurology Publishes Data From Alkermes Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1

Alkermes plc (Nasdaq: ALKS) today announced the publication of data from the Vibrance1 phase 2 study of alixorexton in adults with narcolepsy type 1 (NT1) in The Lancet Neurology. Alixorexton is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the...

Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026

INDV's proposed Supernus merger could broaden its CNS portfolio, cut costs and reduce reliance on Sublocade, but closing remains uncertain.

Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?

Indivior's Sublocade growth and cost cuts are lifting earnings and cash flow, but pipeline setbacks, legal risks and valuation add caution.

ALKS Stock Rises 27% in 3 Months: Here's What You Should Know

Alkermes gains 26.5% in three months as strong proprietary product sales and pipeline progress fuel momentum into the rest of 2026.

Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure?

Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure...

Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down

ALKS posts break-even Q2 earnings and tops revenue estimates as product sales surge, with Lumryz adding momentum. The company maintains its 2026 revenue view.

Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Alkermes (ALKS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Alkermes plc

ALKS Stock Surges 15% On Lilly-Centessa Buyout Igniting Sleep Pipeline Hopes

Equity

Neutral Sentiment

Yes, day one

Yes, but I'll wait for reviews

No, too expensive

No, not interested in a foldable

Apple unveiled its first foldable iPhone, reportedly called the iPhone Duo, at its September 9 event, with pricing starting at $2,000 for the 256GB model. Will you buy the $2,000 iPhone Duo? Vote and explain your reasoning in the comments.

Apple ($AAPL) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Stocktwits

) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Current Price	$45.40
Prev Close	$45.49
Open	$45.24
Dividend Yield	0.00%
50-Day Moving Average	$50.23
Beta	0.65
Avg. Volume	1.36M
PE Ratio	117.92

52-Week High	$55.67
52-Week Low	$26.40
Market Capitalization	$7.62B
EPS (Annual)	$1.43
Price to Book	4.21
Revenue Per Employee	$719,950.73

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALKS Fundamentals